Authors
Loading...
This review explores glycoengineering strategies that enhance antibody effector functions, indicating potential for therapeutic improvements.
Serafin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: